Dr Reddy’s Laboratories has terminated its agreement with Novartis India for the distribution and promotion of select pharmaceutical brands in the country, following a change in the latter’s controlling shareholding. The development was disclosed in a regulatory filing, where Dr Reddy’s stated that the agreement, originally signed on February 11, 2022, will now stand terminated.